WHAT IS CERUVIA
Helping patients return to
living their lives to the fullest
Ceruvia Lifesciences is a neurotransformational medicine company relentlessly focused on the development and commercialization of treatments to deliver meaningful relief to patients suffering from hard-to-treat psychiatric and neurological disorders. For too long, these communities have been poorly understood and under-served. At Ceruvia, we believe they no longer have to live this way.
WHAT IS CERUVIA
Helping patients return to
living their lives to the fullest
Ceruvia Lifesciences is a neurotransformational medicine company relentlessly focused on the development and commercialization of treatments to deliver meaningful relief to patients suffering from hard-to-treat psychiatric and neurological disorders. For too long, these communities have been poorly understood and under-served. At Ceruvia, we believe they no longer have to live this way.
WHY CERUVIA
Leveraging psychedelic science
to create life-altering medicine
With a long history of partnership with researchers at Yale University School of Medicine, NYU School of Medicine and Harvard Medical School,
we are advancing clinical research with synthetic psilocybin (SYNP-101) and BOL-148 (NYPRG-101), a non-hallucinogenic analog of LSD,
to establish their safety and efficacy in treating a range of psychiatric and neurological disorders.
WHO IS CERUVIA
Pioneers in psychedelic drug development
Inspired by the potential of psychedelic medicines to alleviate the suffering caused by mental illness, Ceruvia is leading the way to
make these innovative new treatment options a reality. With decades of experience in clinical drug development and commercialization,
together we are pioneering an entirely new approach to meeting the needs of patients.
WHO IS CERUVIA
Pioneers in psychedelic drug development
Inspired by the potential of psychedelic medicines to alleviate the suffering caused by mental illness, Ceruvia is leading the way to
make these innovative new treatment options a reality. With decades of experience in clinical drug development and commercialization,
together we are pioneering an entirely new approach to meeting the needs of patients.